Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KOD - Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company

KOD - Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company

Kodiak Sciences Inc
  • Today, we look at a biotech firm who is developing a portfolio of retina therapeutics built on the company’s antibody biopolymer conjugate platform.
  • Kodiak has late-stage drug candidate targeting wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and diabetic retinopathy.
  • A full investment analysis is presented in the paragraphs below.

For further details see:

Kodiak Sciences: Our Current Take On This Mid-Cap Biotech Company
Stock Information
Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com
Menu
KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...